In: Molecular oncology, 2015, vol. 9, no. 6, p. 1194-1206
STAT3 is a key element in many oncogenic pathways and, like other transcription factors, is an attractive target for development of novel anticancer drugs. However, interfering with STAT3 functions has been a difficult task and very few small molecule inhibitors have made their way to the clinic. OPB‐31121, an anticancer compound currently in clinical trials, has been reported to affect...
|
In: Attention, Perception, & Psychophysics, 2014, vol. 76, no. 7, p. 2080-2102
|
In: Psychonomic Bulletin & Review, 2012, vol. 19, no. 5, p. 779-819
|
In: Psychonomic Bulletin & Review, 2011, vol. 18, no. 1, p. 10-45
|